Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1552
https://www.valueinhealthjournal.com/article/S1098-3015(16)01620-X/fulltext
Title :
Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01620-X&doi=10.1016/j.jval.2016.03.1552
First page :
A143
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
269